Skip to main content
  • Clinical
      |Clinical
    • Acute Coronary Syndromes
    • Cardiac Surgery
    • Covid-19
    • Heart Failure
    • Heart Health
    • Heart Rhythm
    • Hypertension
    • Interventional Cardiology
    • Mitral Valve
    • Pharmaceutics
    • Structural Heart Disease
    • TAVR
    • Tricuspid Valve
    • Vascular & Endovascular
  • Management
      |Management
    • Chest Pain Guidelines
    • Compensation
    • Economics
    • Education & Training
    • Legal News
    • Patient Care
    • Policy & Regulations
    • Professional Associations
    • Quality
    • Revenue
    • Staffing
  • Technology
      |Technology
    • AI
    • Cardiac Imaging
    • Cath Lab
    • CT
    • CVIS
    • ECG
    • Echo
    • EP Lab
    • Informatics
    • MRI
    • Nuclear Cardiology
    • Remote Monitoring
  • Videos
  • Conferences
      |Conferences
    • ACC
    • AHA
    • ASE
    • ASNC
    • ESC
    • EuroPCR
    • HFSA
    • HRS
    • SCAI
    • SCCT
    • SIIM
    • SNMMI
    • STS
    • TCT
    • VIVA
  • Custom Content
      |Custom Content
    • Experience Stories
    • Webinars & Videos
  • Subscribe
  • Forty Under 40 Award
      |Forty Under 40 Award
    • Class of 2026
    • Class of 2025

Search form

Home

News You Need to Know Today
Heart Rhythm: AFib ablation & HCM | Nighttime cardiac arrest | Alcohol & the risk of AFib | NOACs vs. warfarin
Tuesday, January 26, 2021
Link to Twitter Link to Facebook Link to Linkedin Link to Vimeo

Editor's Choice: Heart Rhythm

AFib ablation is effective for HCM patients, leading to long-term rhythm control

Overall, 60% of patients demonstrated complete freedom from recurrences of atrial fibrillation or atrial tachycardias.

READ MORE >
Share on Twitter Share on Facebook Share on Linkedin

AFib ablation is effective for HCM patients, leading to long-term rhythm control

Share on Twitter Share on Facebook Share on Linkedin
Overall, 60% of patients demonstrated complete freedom from recurrences of atrial fibrillation or atrial tachycardias.
READ MORE >

Nighttime cardiac arrest, a ‘perplexing and devastating phenomenon,’ more common among women

Physicians may want to think twice before prescribing certain medications, including drugs for pain or depression, to some female patients, the authors observed. 

READ MORE >
Share on Twitter Share on Facebook Share on Linkedin

Nighttime cardiac arrest, a ‘perplexing and devastating phenomenon,’ more common among women

Share on Twitter Share on Facebook Share on Linkedin
Physicians may want to think twice before prescribing certain medications, including drugs for pain or depression, to some female patients, the authors observed. 
READ MORE >

Alcohol consumption, even just a daily glass of wine, leads to a heightened risk of AFib

Researchers tracked data from more than 107,000 patients, completing what is believed to be the largest study of its kind. 

READ MORE >
wine bottle drunk drinking
Share on Twitter Share on Facebook Share on Linkedin

Alcohol consumption, even just a daily glass of wine, leads to a heightened risk of AFib

Share on Twitter Share on Facebook Share on Linkedin
wine bottle drunk drinking
Researchers tracked data from more than 107,000 patients, completing what is believed to be the largest study of its kind. 
READ MORE >

10 helpful tips for heart rhythm patients as the COVID-19 pandemic continues

The new analysis, published in Circulation: Arrhythmia and Electrophysiology, was designed to help patients stay informed and avoid unnecessary stress during this challenging time. 

READ MORE >
COVID-19 coronavirus burnout depression pandemic
Share on Twitter Share on Facebook Share on Linkedin

10 helpful tips for heart rhythm patients as the COVID-19 pandemic continues

Share on Twitter Share on Facebook Share on Linkedin
COVID-19 coronavirus burnout depression pandemic
The new analysis, published in Circulation: Arrhythmia and Electrophysiology, was designed to help patients stay informed and avoid unnecessary stress during this challenging time. 
READ MORE >

Non‐vitamin K antagonist oral anticoagulants vs. warfarin for AFib patients: What the latest research tells us

Tracking data from more than 10,000 patients, researchers shared their findings in Diabetes, Obesity and Metabolism.

READ MORE >
durbin-ama-opioid. The American College of Cardiology (ACC) and American Heart Association (AHA) have published new guidelines focused on the diagnosis, treatment and management of patients with chronic coronary disease (CCD).
Share on Twitter Share on Facebook Share on Linkedin

Non‐vitamin K antagonist oral anticoagulants vs. warfarin for AFib patients: What the latest research tells us

Share on Twitter Share on Facebook Share on Linkedin
durbin-ama-opioid. The American College of Cardiology (ACC) and American Heart Association (AHA) have published new guidelines focused on the diagnosis, treatment and management of patients with chronic coronary disease (CCD).
Tracking data from more than 10,000 patients, researchers shared their findings in Diabetes, Obesity and Metabolism.
READ MORE >

American College of Cardiology shares new guidelines for treating patients with anticoagulant and antiplatelet therapy

The ACC is celebrating the holiday season with a new gift for cardiologists.

READ MORE >
women doctors
Share on Twitter Share on Facebook Share on Linkedin

American College of Cardiology shares new guidelines for treating patients with anticoagulant and antiplatelet therapy

Share on Twitter Share on Facebook Share on Linkedin
women doctors
The ACC is celebrating the holiday season with a new gift for cardiologists.
READ MORE >

Philips acquires US-based heart monitoring specialists for $2.8B

BioTelemetry made $439 million in sales in 2019, with a significant portion of that coming from solutions related to heart rhythm disorders.

READ MORE >
According to calculations comparing catheter ablation with drug therapy, the additional quality-adjusted life-years that can result from the treatment justify its increased costs. 
Share on Twitter Share on Facebook Share on Linkedin

Philips acquires US-based heart monitoring specialists for $2.8B

Share on Twitter Share on Facebook Share on Linkedin
According to calculations comparing catheter ablation with drug therapy, the additional quality-adjusted life-years that can result from the treatment justify its increased costs. 
BioTelemetry made $439 million in sales in 2019, with a significant portion of that coming from solutions related to heart rhythm disorders.
READ MORE >

Immune checkpoint inhibitors increase risk of myocarditis, arrhythmias, heart failure and CV death

The study’s authors tracked data from more than 13,000 patients with malignant melanoma and more than 25,000 patients with lung cancer.

READ MORE >
heart_rate.png
Share on Twitter Share on Facebook Share on Linkedin

Immune checkpoint inhibitors increase risk of myocarditis, arrhythmias, heart failure and CV death

Share on Twitter Share on Facebook Share on Linkedin
heart_rate.png
The study’s authors tracked data from more than 13,000 patients with malignant melanoma and more than 25,000 patients with lung cancer.
READ MORE >

Innovate Healthcare thanks our partners for supporting our newsletters.
Sponsorship has no influence on editorial content.

Interested in reaching our audiences, contact our team

*|LIST:ADDRESSLINE|*

You received this email because you signed up for newsletters from Innovate Healthcare.
Change your preferences or unsubscribe here

Contact Us  |  Unsubscribe from all  |  Privacy Policy

© Innovate Healthcare, a TriMed Media brand
Innovate Healthcare

Recent Newsletters

Week in Review: Americans keep poisoning themselves | Device recalled over safety concerns | ACC takes on antiplatelet therapies
AI works behind the scenes | CCTA scan delivers wake-up call | The future of FFR-CT | Subtle heart changes linked to cancer risk
Looking Back: Is coffee bad for the heart? | Procedure kit recalls | Cardiologist gets wake-up call | TAVR policy changes
Compensation still on the rise | Procedure kits recalled | A new definition of heart failure | Cardiologist named AHA president
New antiplatelet recommendations | Heart failure drug recalled | Imaging tech makes US debut | Conavi Medical's good news
Safety concerns lead to new recall | FDA approves surgical device | Parents in jail after obese son's death | A fraud warning
AI making an impact behind the scenes | New EARLY TAVR data | Americans keep poisoning themselves with semaglutide

Pagination

    • Current page 1
    • Page 2
    • Page 3
    • Page 4
    • Page 5
    • Page 6
    • Page 7
    • Page 8
    • Page 9 …
    • Next page ››
    • Last page Last »
  • Home
  • News
  • Article Archive
  • Custom Content
  • Webinars
  • Press Releases
  • Content Studio
  • Advertising
  • Submit Press Release
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • Cardiovascular Business
  • HealthExec
  • Radiology Business
 
© 2026 Innovate Healthcare | All Rights Reserved. | Terms of Use | Privacy Policy
 
Design by Adaptive Theme